ASTERA LABS INC (ALAB) Stock Fundamental Analysis

NASDAQ:ALAB • US04626A1034

132.62 USD
+3.04 (+2.35%)
At close: Feb 19, 2026
132 USD
-0.62 (-0.47%)
Pre-Market: 2/20/2026, 7:22:09 AM
Fundamental Rating

6

ALAB gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. ALAB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALAB is valued quite expensive, but it does show an excellent growth. This makes ALAB very considerable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ALAB was profitable.
  • In the past year ALAB had a positive cash flow from operations.
ALAB Yearly Net Income VS EBIT VS OCF VS FCFALAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • With an excellent Return On Assets value of 14.31%, ALAB belongs to the best of the industry, outperforming 87.61% of the companies in the same industry.
  • ALAB's Return On Equity of 16.07% is amongst the best of the industry. ALAB outperforms 81.42% of its industry peers.
  • ALAB's Return On Invested Capital of 9.79% is fine compared to the rest of the industry. ALAB outperforms 78.76% of its industry peers.
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROIC 9.79%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALAB Yearly ROA, ROE, ROICALAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • ALAB has a Profit Margin of 25.70%. This is amongst the best in the industry. ALAB outperforms 84.07% of its industry peers.
  • ALAB's Operating Margin of 20.34% is fine compared to the rest of the industry. ALAB outperforms 78.76% of its industry peers.
  • ALAB has a better Gross Margin (75.69%) than 94.69% of its industry peers.
  • ALAB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
ALAB Yearly Profit, Operating, Gross MarginsALAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

8

2. Health

2.1 Basic Checks

  • ALAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALAB has more shares outstanding
  • ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALAB Yearly Shares OutstandingALAB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
ALAB Yearly Total Debt VS Total AssetsALAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • ALAB has an Altman-Z score of 81.81. This indicates that ALAB is financially healthy and has little risk of bankruptcy at the moment.
  • ALAB has a Altman-Z score of 81.81. This is amongst the best in the industry. ALAB outperforms 98.23% of its industry peers.
  • ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 81.81
ROIC/WACC0.91
WACC10.81%
ALAB Yearly LT Debt VS Equity VS FCFALAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 10.24 indicates that ALAB has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 10.24, ALAB belongs to the top of the industry, outperforming 94.69% of the companies in the same industry.
  • ALAB has a Quick Ratio of 9.79. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 9.79, ALAB belongs to the best of the industry, outperforming 95.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.24
Quick Ratio 9.79
ALAB Yearly Current Assets VS Current LiabilitesALAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.00% over the past year.
  • Looking at the last year, ALAB shows a very strong growth in Revenue. The Revenue has grown by 115.13%.
  • ALAB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 120.18% yearly.
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%

3.2 Future

  • Based on estimates for the next years, ALAB will show a very strong growth in Earnings Per Share. The EPS will grow by 25.00% on average per year.
  • The Revenue is expected to grow by 19.33% on average over the next years. This is quite good.
EPS Next Y30.96%
EPS Next 2Y34.29%
EPS Next 3Y38.21%
EPS Next 5Y25%
Revenue Next Year60.49%
Revenue Next 2Y48.53%
Revenue Next 3Y41.59%
Revenue Next 5Y19.33%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALAB Yearly Revenue VS EstimatesALAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
ALAB Yearly EPS VS EstimatesALAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 72.08, which means the current valuation is very expensive for ALAB.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALAB is on the same level as its industry peers.
  • ALAB is valuated expensively when we compare the Price/Earnings ratio to 27.09, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 55.04, which means the current valuation is very expensive for ALAB.
  • ALAB's Price/Forward Earnings is on the same level as the industry average.
  • ALAB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.98.
Industry RankSector Rank
PE 72.08
Fwd PE 55.04
ALAB Price Earnings VS Forward Price EarningsALAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALAB.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALAB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 79.5
EV/EBITDA 112.01
ALAB Per share dataALAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ALAB's earnings are expected to grow with 38.21% in the coming years.
PEG (NY)2.33
PEG (5Y)N/A
EPS Next 2Y34.29%
EPS Next 3Y38.21%

0

5. Dividend

5.1 Amount

  • No dividends for ALAB!.
Industry RankSector Rank
Dividend Yield 0%

ASTERA LABS INC

NASDAQ:ALAB (2/19/2026, 8:00:01 PM)

Premarket: 132 -0.62 (-0.47%)

132.62

+3.04 (+2.35%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners76.83%
Inst Owner Change2.6%
Ins Owners11.28%
Ins Owner Change-9.66%
Market Cap22.40B
Revenue(TTM)852.52M
Net Income(TTM)219.13M
Analysts80.71
Price Target207.65 (56.58%)
Short Float %7.12%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.96%
Min EPS beat(2)10.58%
Max EPS beat(2)23.34%
EPS beat(4)4
Avg EPS beat(4)20.27%
Min EPS beat(4)10.58%
Max EPS beat(4)33.19%
EPS beat(8)8
Avg EPS beat(8)91.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.89%
Min Revenue beat(2)6.34%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)6.73%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)8
Avg Revenue beat(8)8.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.82%
PT rev (3m)6.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.18%
EPS NY rev (1m)0.04%
EPS NY rev (3m)12.25%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)2.66%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)7.33%
Valuation
Industry RankSector Rank
PE 72.08
Fwd PE 55.04
P/S 26.27
P/FCF 79.5
P/OCF 70.15
P/B 16.43
P/tB 16.43
EV/EBITDA 112.01
EPS(TTM)1.84
EY1.39%
EPS(NY)2.41
Fwd EY1.82%
FCF(TTM)1.67
FCFY1.26%
OCF(TTM)1.89
OCFY1.43%
SpS5.05
BVpS8.07
TBVpS8.07
PEG (NY)2.33
PEG (5Y)N/A
Graham Number18.28
Profitability
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROCE 12.4%
ROIC 9.79%
ROICexc 65.25%
ROICexgc 65.25%
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
FCFM 33.05%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 549.77%
Cap/Sales 4.4%
Interest Coverage 250
Cash Conversion 177.14%
Profit Quality 128.58%
Current Ratio 10.24
Quick Ratio 9.79
Altman-Z 81.81
F-Score6
WACC10.81%
ROIC/WACC0.91
Cap/Depr(3y)596.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
EPS Next Y30.96%
EPS Next 2Y34.29%
EPS Next 3Y38.21%
EPS Next 5Y25%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%
Revenue Next Year60.49%
Revenue Next 2Y48.53%
Revenue Next 3Y41.59%
Revenue Next 5Y19.33%
EBIT growth 1Y249.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.46%
EBIT Next 3Y43.48%
EBIT Next 5Y29.17%
FCF growth 1Y175.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.62%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / ALAB FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 6 / 10 to ALAB.


Can you provide the valuation status for ASTERA LABS INC?

ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.


How profitable is ASTERA LABS INC (ALAB) stock?

ASTERA LABS INC (ALAB) has a profitability rating of 5 / 10.


Can you provide the financial health for ALAB stock?

The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.